Evidence map›Paper›PMID 32507557›Full record

ArticleL'Encephale2020

[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].

A Sauvaget, R Dumont, N Bukowski, O Bonnot, R Auffret, E Poulet, D Szekely, C Quiles, A Yrondi, M Plaze and 3 more

Open access · hybridAbstract read
In one paragraph

Article in L'Encephale, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. The Impact of COVID-19 on Brain Stimulation Therapy.The Psychiatric clinics of North America · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 2 countries.

A SauvagetFrench Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Nantes Université, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France. Electronic address: anne.sauvaget@chu-nantes.fr.
R DumontCHU de Nantes, Department of Anesthesiology and Critical Care Medicine, Hôtel-Dieu-PTMC, Nantes, France.
N BukowskiCHU Nantes, Department of Addictology and Psychiatry, Nantes, France.
O BonnotChild and Adolescent Psychiatry Department, CHU and University of Nantes, Nantes, France.
R AuffretCHU Nantes, Department of Addictology and Psychiatry, Nantes, France.
E PouletFrench Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Centre hospitalier Le Vinatier, Bron, France; Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 69000 Lyon, France; University Lyon 1, 69000 Villeurbanne, France; Department of Emergency Psychiatry, hospices civils de Lyon, University Hospital Edouard-Herriot, Lyon, France.
D SzekelyFrench Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Department of psychiatry, centre hospitalier Princesse-Grace, 98000 Monaco, France.
C QuilesCentre hospitalier Charles-Perrens, 33000 Bordeaux, France.
A YrondiFrench Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Service de psychiatrie et de psychologie médicale, centre expert dépression résistante fondamental, CHU de Toulouse, Toulouse, France; Inserm, UPS, ToNIC Toulouse NeuroImaging Center, hôpital Purpan, université de Toulouse, Toulouse, France.
M PlazeFrench Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Université de Paris, 75005 Paris, France; Service hospitalo-universitaire, GHU de Paris psychiatrie & neurosciences, 75014 Paris, France.
W de CarvalhoPôle ECT - groupe SINOUÉ, clinique BELLEVUE, 92190 Meudon, France.
A AmadInserm, U1172 - LilNCog - Lille Neuroscience & Cognition, CHU de Lille, université de Lille, 59000 Lille, France.
S BulteauFrench Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; CHU Nantes, Department of Addictology and Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes, France.
Centre Hospitalier Charles Perrens · FRCentre Hospitalier Universitaire de Nantes · FRClinique Ambroise Paré · FRInserm · FRLaboratoire Motricité, Interactions, Performance · FRNantes Université · FRPrincess Grace Hospital Centre · MCUniversité Claude Bernard Lyon 1 · FRUniversité de Tours · FRUniversité Paris Cité · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has had major consequences for the organization of care. In France and around the world, centers practicing electroconvulsive therapy (ECT) have seen their activity decrease, or even stop for many reasons. In this context, maintaining or resuming this essential therapeutic activity for many patients suffering from psychiatric disorders requires material, human and logistical adaptations that should be supervised. The objective of this collective and national work is to offer simple recommendations that can be applied immediately by any healthcare establishment, public or private, practicing ECT. They are the result of feedback from multiprofessional and inter-establishment experiences. Declined in three stages, these recommendations are accompanied by a practical sheet which describes in detail the necessary conditions and prerequisites for any resumption of ECT activity.

Indexed as

BetacoronavirusElectroconvulsive TherapyPractice Guidelines as TopicCommunicable Disease ControlCoronavirus InfectionsCOVID-19FranceHospitals, PrivateHospitals, PublicHumansNursing HomesPandemicsPatient SafetyPatient SelectionPneumonia, ViralProcedures and Techniques UtilizationAccèsAccessibilityCOVID-19Electroconvulsive therapyÉlectroconvulsivothérapieGuidelinesRecommandations

Identifiers

PMID32507557
PMCPMC7271849
OpenAlexW3033825430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.